AAAAAA

   
Results: 1-23 |
Results: 23
Persistence of atherosclerotic plaque but reduced aneurysm formation in mice with stromelysin-1 (MMP-3) gene inactivation
Authors: Silence, J Lupu, F Collen, D Lijnen, HR
Citation: J. Silence et al., Persistence of atherosclerotic plaque but reduced aneurysm formation in mice with stromelysin-1 (MMP-3) gene inactivation, ART THROM V, 21(9), 2001, pp. 1440-1445
Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis
Authors: Angelillo-Scherrer, A de Frutos, PG Aparicio, C Melis, E Savi, P Lupu, F Arnout, J Dewerchin, M Hoylaerts, MF Herbert, M Collen, D Dahlback, B Carmeliet, P
Citation: A. Angelillo-scherrer et al., Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis, NAT MED, 7(2), 2001, pp. 215-221
Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration
Authors: Oosthuyse, B Moons, L Storkebaum, E Beck, H Nuyens, D Brusselmans, K Van Dorpe, J Hellings, P Gorselink, M Heymans, S Theilmeier, G Dewerchin, M Laudenbach, V Vermylen, P Raat, H Acker, T Vleminckx, V Van den Bosch, L Cashman, N Fujisawa, H Drost, MR Sciot, R Bruyninckx, F Hicklin, DJ Ince, C Gressens, P Lupu, F Plate, KH Robberecht, W Herbert, JM Collen, D Carmeliet, P
Citation: B. Oosthuyse et al., Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration, NAT GENET, 28(2), 2001, pp. 131-138
Release of soluble urokinase receptor from vascular cells
Authors: Chavakis, T Willuweit, AK Lupu, F Preissner, KT Kanse, SM
Citation: T. Chavakis et al., Release of soluble urokinase receptor from vascular cells, THROMB HAEM, 86(2), 2001, pp. 686-693
Adipose tissue expression of gelatinases in mouse models of obesity
Authors: Lijnen, HR Maquoi, E Holvoet, P Mertens, A Lupu, F Morange, P Alessi, MC Juhan-Vague, I
Citation: Hr. Lijnen et al., Adipose tissue expression of gelatinases in mouse models of obesity, THROMB HAEM, 85(6), 2001, pp. 1111-1116
Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth
Authors: Lupu, F Terwilliger, JD Lee, K Segre, GV Efstratiadis, A
Citation: F. Lupu et al., Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth, DEVELOP BIO, 229(1), 2001, pp. 141-162
Aberrant fibrin formation and cross-linking of fibrinogen Nieuwegein, a variant with a shortened A alpha-chain, alters endothelial capillary tube formation
Authors: Collen, A Maas, A Koolstra, T Lupu, F Grimbergen, J Haas, FJLM Biesma, DH Koolwijk, P Koopman, J van Hinsbergh, VWM
Citation: A. Collen et al., Aberrant fibrin formation and cross-linking of fibrinogen Nieuwegein, a variant with a shortened A alpha-chain, alters endothelial capillary tube formation, BLOOD, 97(4), 2001, pp. 973-980
Expression, localization, and activity of tissue factor pathway inhibitor in normal and atherosclerotic human vessels
Authors: Crawley, J Lupu, F Westmuckett, AD Severs, NJ Kakkar, VV Lupu, C
Citation: J. Crawley et al., Expression, localization, and activity of tissue factor pathway inhibitor in normal and atherosclerotic human vessels, ART THROM V, 20(5), 2000, pp. 1362-1373
Colocalization of thrombin, PAI-1, and vitronectin in the atherosclerotic vessel wall - A potential regulatory mechanism of thrombin activity by PAI-1/vitronectin complexes
Authors: Stoop, AA Lupu, F Pannekoek, H
Citation: Aa. Stoop et al., Colocalization of thrombin, PAI-1, and vitronectin in the atherosclerotic vessel wall - A potential regulatory mechanism of thrombin activity by PAI-1/vitronectin complexes, ART THROM V, 20(4), 2000, pp. 1143-1149
Fluid flow induces upregulation of synthesis and release of tissue factor pathway inhibitor in vitro
Authors: Westmuckett, AD Lupu, C Roquefeuil, S Krausz, T Kakkar, VV Lupu, F
Citation: Ad. Westmuckett et al., Fluid flow induces upregulation of synthesis and release of tissue factor pathway inhibitor in vitro, ART THROM V, 20(11), 2000, pp. 2474-2482
Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomas
Authors: Verheul, HMW Hoekman, K Lupu, F Broxterman, HJ van der Valk, P Kakkar, AK Pinedo, HM
Citation: Hmw. Verheul et al., Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomas, CLIN CANC R, 6(1), 2000, pp. 166-171
In situ analysis of tissue factor-dependent thrombin generation in human atherosclerotic vessels
Authors: Westmuckett, AD Lupu, C Goulding, DA Das, S Kakkar, VV Lupu, F
Citation: Ad. Westmuckett et al., In situ analysis of tissue factor-dependent thrombin generation in human atherosclerotic vessels, THROMB HAEM, 84(5), 2000, pp. 904-911
CD9 gene deficiency does not affect smooth muscle cell migration and neointima formation after vascular injury in mice
Authors: Lijnen, HR Lupu, F Collen, D Le Naour, F Boucheix, C
Citation: Hr. Lijnen et al., CD9 gene deficiency does not affect smooth muscle cell migration and neointima formation after vascular injury in mice, THROMB HAEM, 83(6), 2000, pp. 956-961
Unfractionated and low molecular weight heparin affect fibrin structure and angiogenesis in vitro
Authors: Collen, A Smorenburg, SM Peters, E Lupu, F Koolwijk, P Van Noorden, C van Hinsbergh, VWM
Citation: A. Collen et al., Unfractionated and low molecular weight heparin affect fibrin structure and angiogenesis in vitro, CANCER RES, 60(21), 2000, pp. 6196-6200
Different mechanisms define the antiadhesive function of high molecular weight kininogen in integrin- and urokinase receptor-dependent interactions
Authors: Chavakis, T Kanse, SM Lupu, F Hammes, HP Muller-Esterl, W Pixley, RA Colman, RW Preissner, KT
Citation: T. Chavakis et al., Different mechanisms define the antiadhesive function of high molecular weight kininogen in integrin- and urokinase receptor-dependent interactions, BLOOD, 96(2), 2000, pp. 514-522
Distinct localization and function of (IP3)-I-1,4,5 receptor subtypes and the (IP4)-I-1,3,4,5 receptor GAP1(IP4BP) in highly purified human platelet membranes
Authors: El-Daher, SS Patel, Y Siddiqua, A Hassock, S Edmunds, S Maddison, B Patel, G Goulding, D Lupu, F Wojcikiewicz, RJH Authi, KS
Citation: Ss. El-daher et al., Distinct localization and function of (IP3)-I-1,4,5 receptor subtypes and the (IP4)-I-1,3,4,5 receptor GAP1(IP4BP) in highly purified human platelet membranes, BLOOD, 95(11), 2000, pp. 3412-3422
Cellular effects of heparin on the production and release of tissue factorpathway inhibitor in human endothelial cells in culture
Authors: Lupu, C Poulsen, E Roquefeuil, S Westmuckett, AD Kakkar, VV Lupu, F
Citation: C. Lupu et al., Cellular effects of heparin on the production and release of tissue factorpathway inhibitor in human endothelial cells in culture, ART THROM V, 19(9), 1999, pp. 2251-2262
Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF(164) and VEGF(188)
Authors: Carmeliet, P Ng, YS Nuyens, D Theilmeier, G Brusselmans, K Cornelissen, I Ehler, E Kakkar, VV Stalmans, I Mattot, V Perriard, JC Dewerchin, M Flameng, W Nagy, A Lupu, F Moons, L Collen, D D'Amore, PA Shima, DT
Citation: P. Carmeliet et al., Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF(164) and VEGF(188), NAT MED, 5(5), 1999, pp. 495-502
Inhibition of plasminogen activators or matrix metalloproteinases preventscardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure
Authors: Heymans, S Luttun, A Nuyens, D Theilmeier, G Creemers, E Moons, L Dyspersin, GD Cleutjens, JPM Shipley, M Angellilo, A Levi, M Nube, O Baker, A Keshet, E Lupu, F Herbert, JM Smits, JFM Shapiro, SD Baes, M Borgers, M Collen, D Daemen, MJAP Carmeliet, P
Citation: S. Heymans et al., Inhibition of plasminogen activators or matrix metalloproteinases preventscardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure, NAT MED, 5(10), 1999, pp. 1135-1142
Tissue-selective expression of dominant-negative proteins for the regulation of vascular smooth muscle cell proliferation
Authors: Schmitt, JF Keogh, MC Dennehy, U Chen, D Lupu, F Weston, K Taylor, D Kakkar, VV Lemoine, NR
Citation: Jf. Schmitt et al., Tissue-selective expression of dominant-negative proteins for the regulation of vascular smooth muscle cell proliferation, GENE THER, 6(6), 1999, pp. 1184-1191
Acute release of tissue factor pathway inhibitor after in vivo thrombin generation in baboons
Authors: Lupu, C Kruithof, EKO Kakkar, VV Lupu, F
Citation: C. Lupu et al., Acute release of tissue factor pathway inhibitor after in vivo thrombin generation in baboons, THROMB HAEM, 82(6), 1999, pp. 1652-1658
Temporal and topographic matrix metalloproteinase expression after vascular injury in mice
Authors: Lijnen, HR Lupu, F Moons, L Carmeliet, P Goulding, D Collen, D
Citation: Hr. Lijnen et al., Temporal and topographic matrix metalloproteinase expression after vascular injury in mice, THROMB HAEM, 81(5), 1999, pp. 799-807
Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis
Authors: Carmeliet, P Lampugnani, MG Moons, L Breviario, F Compernolle, V Bono, F Balconi, G Spagnuolo, R Oosthuyse, B Dewerchin, M Zanetti, A Angellilo, A Mattot, V Nuyens, D Lutgens, E Clotman, F de Ruiter, MC Gittenberger-de Groot, A Poelmann, R Lupu, F Herbert, JM Collen, D Dejana, E
Citation: P. Carmeliet et al., Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis, CELL, 98(2), 1999, pp. 147-157
Risultati: 1-23 |